Citadel Advisors’s Pomdoctor Ltd POM Stock Holding History

Citadel Advisors’s Portfolio POM Stock Details POM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.8K	Buy	21,273 +1,017	+5%	+$3.9K	﹤0.01%	13298
2026 Q1	$93.6K	Buy	+20,256	New	+$104K	﹤0.01%	12069

Other funds holding POM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Citadel Advisors's POM Position: Q2 2026 in Review

Citadel Advisors increased its Pomdoctor Ltd (POM) stake by 5% in Q2 2026, buying an estimated $3.9K and bringing the position to 21,273 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #13298.

Citadel Advisors first reported a position in POM in Q1 2026 and has held it in 2 quarters since. The position peaked at $93.6K in Q1 2026. 6 funds tracked by Wall St. Rank hold POM as of Q2 2026.

Citadel Advisors held 21,273 shares of Pomdoctor Ltd worth $30.8K as of Q2 2026.
Citadel Advisors bought 1,017 Pomdoctor Ltd shares in Q2 2026, an estimated $3.9K.
Pomdoctor Ltd made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13298 holding.
Citadel Advisors first reported a position in Pomdoctor Ltd in Q1 2026 and has held it in 2 quarters since.
Citadel Advisors's Pomdoctor Ltd position peaked at $93.6K in Q1 2026.
6 funds tracked by Wall St. Rank held Pomdoctor Ltd as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.